Literature DB >> 10825131

Radiation and the Apo2L/TRAIL apoptotic pathway preferentially inhibit the colonization of premalignant human breast cells overexpressing cyclin D1.

Q Zhou1, P Fukushima, W DeGraff, J B Mitchell, M Stetler Stevenson, A Ashkenazi, P S Steeg.   

Abstract

The role of cyclin D1 overexpression in human breast premalignancy was investigated using immortal, nontumorigenic MCF-10A cells. Previous work documented that cyclin D1 overexpression promoted in vitro anchorage-independent colonization. We now report that the colonization of MCF-10A cyclin D1 transfectants was preferentially inhibited by gamma-radiation and specific classes of apoptosis inducers [Apo-2 ligand (Apo-2L), but not tumor necrosis factor alpha]. Antibody inhibition studies and semiquantitative PCR indicated that radiation inhibition of colonization was partially mediated via the Apo2L/TRAIL pathway. The apoptotic removal of cyclin D1-overexpressing, colonization-competent premalignant breast cells by Apo2L/TRAIL or other biologicals may represent a novel approach to the prevention of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825131

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  New roles of cyclin D1.

Authors:  Richard G Pestell
Journal:  Am J Pathol       Date:  2013-07       Impact factor: 4.307

Review 2.  The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis.

Authors:  Xiaomin Lou; Ju Zhang; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Cell Cycle       Date:  2014-05-05       Impact factor: 4.534

3.  Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo.

Authors:  Motoo Nagane; Saki Shimizu; Eiji Mori; Shiro Kataoka; Yoshiaki Shiokawa
Journal:  Neuro Oncol       Date:  2010-02-11       Impact factor: 12.300

4.  Alternative cyclin D1 splice forms differentially regulate the DNA damage response.

Authors:  Zhiping Li; Xuanmao Jiao; Chenguang Wang; L Andrew Shirley; Hany Elsaleh; Olav Dahl; Min Wang; Evi Soutoglou; Erik S Knudsen; Richard G Pestell
Journal:  Cancer Res       Date:  2010-10-12       Impact factor: 12.701

5.  Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells.

Authors:  Mathew C Casimiro; Gabriele Di Sante; Xiaoming Ju; Zhiping Li; Ke Chen; Marco Crosariol; Ismail Yaman; Michael Gormley; Hui Meng; Michael P Lisanti; Richard G Pestell
Journal:  Cancer Res       Date:  2015-11-18       Impact factor: 12.701

Review 6.  The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies.

Authors:  Dao M Nguyen; Mustafa Hussain
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

7.  Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis.

Authors:  Katie R Hagen; Xiangbin Zeng; Mi-Young Lee; Shannon Tucker Kahn; Mary Kathryn Harrison Pitner; Sandra S Zaky; Yuan Liu; Ruth M O'Regan; Xingming Deng; Harold I Saavedra
Journal:  Cell Div       Date:  2013-07-25       Impact factor: 5.130

Review 8.  Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer.

Authors:  Gabriele Di Sante; Agnese Di Rocco; Claudia Pupo; Mathew C Casimiro; Richard G Pestell
Journal:  Oncotarget       Date:  2017-07-20

9.  Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.

Authors:  K Jirström; A Ringberg; M Fernö; L Anagnostaki; G Landberg
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.